Addressing how the UK life sciences can be prioritised more often by global Pharmaceutical and Biotech firms

In the latest life sciences round table, Compass Carter Osborne’s Director, Tarquin Bennett-Coles was invited by sister brand, Carrot Recruitment, to contribute towards an engaging discussion addressing the changes required for the UK life sciences sector need to make in order to be prioritised more often by global Pharmaceutical and Biotech firms as a leading market for new product launches.

Spearheaded by Carrot Recruitment’s Founding Director, Martin Anderson, with CCO non-executive advisor, Geoff Dobson chairing the expert panel of participants, an erudite cohort of Market Access, RWE, and HEOR leaders from across the life sciences spectrum contributed towards an insightful morning, covering off a range of topics including:

1. How is the UK market currently perceived as a place to launch and why?
2. What are the most attractive features of our home market, and conversely, what are the inhibitors?
3. How do VPAG and other pricing and reimbursement models impact upon the UK market?
4. Does the European JCA (EU HTAR) provide an opportunity for the UK?
5. Do the challenges differ for rare disease product launch? Are they the same, but amplified challenges?
6. Are regulatory agencies attuned to industry’s increased utilisation of RWE?
7. What can be done to improve the situation?

We’d like to extend our thanks to all participants:

• Geoff Dobson, Discussion Chair, Compass Carter Osborne, Non-Executive Director
• Martin Anderson, Founding Director, Carrot Recruitment
• Tarquin Bennett-Coles, Director, Compass Carter Osborne
• Vladimir Babiy, Associate Director Global Health Economics and Outcomes Research, Novartis
• Judit Banhazi, VP Value & Access, Connect HEOR
• Tijana Ignjatovic, Executive Director Global Market Access & Pricing, Genesis Research Group
• Ross Selby, Value, Access & External Affairs Director, ITF Pharma
• Andrew Smith, UK Market Access Manager, Sun Pharma
• Nyree Sweeney, Executive Director Global Market Access, Menarini
• Oliver Jack, Market Access Lead, Independent
• Aodan Tynan, VP, Head of Global Market Access, Astellas
• Jasim Uddin, Market Access Practice Lead, LCP Health Analytics

To obtain a copy of the full report and the detailed discussions, download your copy below.